Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties

Abstract

Abnormalities in cellular differentiation are frequent occurrences in human cancers. Treatment of human melanoma cells with recombinant fibroblast interferon (IFN-β) and the protein kinase C activator mezerein (MEZ) results in an irreversible loss in growth potential, suppression of tumorigenic properties and induction of terminal cell differentiation. Subtraction hybridization identified melanoma differentiation associated gene-7 (mda-7), as a gene induced during these physiological changes in human melanoma cells. Ectopic expression of mda-7 by means of a replication defective adenovirus results in growth suppression and induction of apoptosis in a broad spectrum of additional cancers, including melanoma, glioblastoma multiforme, osteosarcoma and carcinomas of the breast, cervix, colon, lung, nasopharynx and prostate. In contrast, no apparent harmful effects occur when mda-7 is expressed in normal epithelial or fibroblast cells. Human clones of mda-7 were isolated and its organization resolved in terms of intron/exon structure and chromosomal localization. Hu-mda-7 encompasses seven exons and six introns and encodes a protein with a predicted size of 23.8 kDa, consisting of 206 amino acids. Hu-mda-7 mRNA is stably expressed in the thymus, spleen and peripheral blood leukocytes. De novo mda-7 mRNA expression is also detected in human melanocytes and expression is inducible in cells of melanocyte/melanoma lineage and in certain normal and cancer cell types following treatment with a combination of IFN-β plus MEZ. Mda-7 expression is also induced during megakaryocyte differentiation induced in human hematopoietic cells by treatment with TPA (12-O-tetradecanoyl phorbol-13-acetate). In contrast, de novo expression of mda-7 is not detected nor is it inducible by IFN-β+MEZ in a spectrum of additional normal and cancer cells. No correlation was observed between induction of mda-7 mRNA expression and growth suppression following treatment with IFN-β+MEZ and induction of endogenous mda-7 mRNA by combination treatment did not result in significant intracellular MDA-7 protein. Radiation hybrid mapping assigned the mda-7 gene to human chromosome 1q, at 1q 32.2 to 1q41, an area containing a cluster of genes associated with the IL-10 family of cytokines. Mda-7 represents a differentiation, growth and apoptosis associated gene with potential utility for the gene-based therapy of diverse human cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Alitalo R . 1990 Leuk. Res. 14: 501–514

  • Armstrong BK, Kricker A . 1994 Cancer Surv. 19/20: 219–240

  • Bishop JM . 1991 Cell 64: 235–248

  • Blumberg H, Conklin D, Xu W, Grossmann A, Brender T, Carollo S, Eagan M, Foster D, Haldeman B, Hammond A, Haughen H, Jelinek L, Kelly J, Madden K, Maurer M, Parrish-Novak J, Prunkard D, Sexson S, Sprecher C, Waggie K, West J, Whitmore T, Yao L, Kuechle M, Dale B, Chandrasekher Y . 2001 Cell 104: 9–19

  • Breathnach R, Benoist C, O'Hare K, Gannon F, Chambon P . 1978 Proc. Natl. Acad. Sci. USA 75: 4853–4857

  • Breathnach R, Chambon P . 1981 Annu. Rev. Biochem. 50: 349–383

  • Chaiken IM, Williams WV . 1996 Trends Biotechnol. 14: 369–375

  • Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM . 1999 Cell Tissue Res. 296: 331–337

  • Clark W . 1991 Br. J. Cancer 64: 631–644

  • DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM . 1996 Nat. Genet. 14: 457–460

  • Falck-Pedersen E, Heinflink M, Alvira M, Nussenzveig DR, Gershengorn MC . 1994 Mol. Pharmacol. 45: 684–689

  • Fisher PB . 1984 Tumor Promotion and Cocarcinogenesis In Vitro, Mechanisms of Tumor Promotion. Slaga TJ (ed) CRC Press Inc.: Boca Raton, Florida pp. 57–83

  • Fisher PB, Prignoli DR, Hermo Jr H, Weinstein IB, Pestka S . 1985 J. Interferon Res. 5: 11–22

  • Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vasquez N, Pestka S, Donnelly RP, Kotenko SV . 2000 Genes Immun. 1: 442–450

  • Graham FL, Smiley J, Russell WC, Nairn R . 1977 J. Gen. Virol. 36: 59–72

  • Graham GM, Guarini L, Moulton TA, Datta S, Ferrone S, Giacomini P, Kerbel RS, Fisher PB . 1991 Cancer Immunol. Immunotherap. 32: 382–390

  • Guarini L, Temponi M, Bruce JN, Bollon AP, Duigou GJ, Moulton TA, Ferrone S, Fisher PB . 1990 Intl. J. Cancer 46: 1041–1047

  • Herlyn M, Berking C, Li G, Satyamoorthy K . 2000 Melanoma Res. 10: 303–312

  • Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB . 1999a Oncogene 18: 3546–3552

  • Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB . 1999b Gene 236: 125–131

  • Jiang H, Fisher PB . 1993 Mol. Cell. Differ. 1: 285–299

  • Jiang H, Kang D-C, Alexandre D, Fisher PB . 2000 Proc. Natl. Acad. Sci. USA 93: 9160–9165

  • Jiang H, Lin J, Fisher PB . 1994 Mol. Cell. Differ. 2: 221–239

  • Jiang H, Lin JJ, Su Z-Z, Goldstein NI, Fisher PB . 1995b Oncogene 11: 2477–2486

  • Jiang H, Lin J, Su Z-Z, Kerbel RS, Herlyn M, Weissman RB, Welch D, Fisher PB . 1995a Oncogene 10: 1855–1864

  • Jiang H, Su Z-Z, Boyd J, Fisher PB . 1993 Mol. Cell. Differ. 1: 41–66

  • Jiang H, Su Z-Z, Lin JJ, Goldstein NI, Young CSH, Fisher PB . 1996 Proc. Natl. Acad. Sci. USA 93: 9160–9165

  • Kang D-C, Jiang H, Wu Q, Pestka S, Fisher PB . 2001 Gene 267: 233–242

  • Kang D-C, LaFrance R, Su Z-Z, Fisher PB . 1998 Proc. Natl. Acad. Sci. USA 95: 13788–13793

  • Kerbel RS, Man MS . 1984 Invasion Metastasis 4: Suppl 1 31–43

  • Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S . 2001 J. Biol. Chem. 276: 2725–2732

  • Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB . 2001 Pharmacol. Therapeut in press

  • Li DQ, Lee SB, Tseng SC . 1999 Curr. Eye Res. 19: 154–161

  • Madireddi MT, Dent P, Fisher PB . 2000a Oncogene 19: 1362–1368

  • Madireddi MT, Dent P, Fisher PB . 2000b J. Cell. Physiol. 185: 36–46

  • Madireddi MT, Su Z-Z, Young CSH, Goldstein NI, Fisher PB . 2000c Adv. Exptl. Med. Biol. 465: 239–261

  • McGrory WJ, Bautista DS, Graham FL . 1988 Virology 163: 614–617

  • Mhashilkar AB, Schrock RD, Hindi M, Liao J, Sieger K, Kourouma F, Zou-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R, Chada S . 2001 Mol. Med. 7: 271–282

  • Miller MS . 1999 J. Foot Ankle Surg. 38: 227–231

  • Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO . 2000 Nat. Genet. 24: 227–235

  • Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, Ramesh R . 2000 Gene Therapy 7: 2051–2057

  • Saito I . 2000 Crit. Rev. Immunol. 20: 153–165

  • Sambrook J, Fritsch EF, Maniatis T . 1989 Cold Spring Harbor Laboratory Press, 2nd ed Cold Spring Harbor, NY

  • Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW . 1996 Proc. Natl. Acad. Sci. USA 93: 10614–10619

  • Soo C, Shaw WW, Freymiller E, Longaker MT, Bertolami CN, Chiu R, Tieu A, Ting K . 1999 J. Cell. Biochem. 74: 1–10

  • Su Z-Z, Goldstein NI, Jiang H, Wang M-N, Duigou GJ, Young CSH, Fisher PB . 1999 Proc. Natl. Acad. Sci. USA 96: 15115–15120

  • Su Z-Z, Madireddi MT, Lin JJ, Young CSH, Kitada S, Reed JC, Goldstein NI, Fisher PB . 1998 Proc. Natl. Acad. Sci. USA 95: 14400–14405

  • Su Z-Z, Shi Y, Fisher PB . 1997 Proc. Natl. Acad. Sci. USA 94: 9125–9130

  • Su Z-Z, Yemul S, Estabrook A, Zimmer SG, Friedman RM, Fisher PB . 1995 Intl. J. Oncology 7: 1279–1284

  • Tonetti DA, Horio M, Collart FR, Huberman E . 1992 Cell Growth Differ. 3: 739–745

  • Vita JR, Edwalds GM, Gorey T, Housepian EM, Fetell MR, Guarini L, Langer JA, Fisher PB . 1988 Anticancer Res. 8: 297–302

  • Vogelstein B, Kinzler KW . 1991 Trends Genet. 9: 138–141

  • Volkert FC, Young CSH . 1983 Virology 125: 175–193

  • Waxman S . 1996 Differentiation Therapy. Waxman S (ed) Serono Symposium Publications, Rome, Italy pp. 1–528

    Google Scholar 

  • Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL . 2000 J. Biol. Chem. 275: 31335–31339

  • Zhang R, Tan Z, Liang P . 2000 J. Biol. Chem. 275: 24436–24443

Download references

Acknowledgements

This study was supported in part by National Institutes of Health grant CA35675, CA80826, Columbia Skin Diseases Research Center (P30-AR44535), the Samuel Waxman Cancer Research Foundation, the Chernow Endowment and Introgen Therapeutics, Inc. MT Madireddi was supported by a fellowship award from the Army Department of Defense Initiative on Breast Cancer (DAMD17-98-1-8053). PB Fisher is the Michael and Stella Chernow Urological Cancer Research Scientist in the Departments of Neurosurgery, Pathology and Urology. We thank Drs Theresa Druck and Kay Hubner for assistance with the chromosomal mapping of mda-7.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul B Fisher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, E., Madireddi, M., Gopalkrishnan, R. et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20, 7051–7063 (2001). https://doi.org/10.1038/sj.onc.1204897

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204897

Keywords

This article is cited by

Search

Quick links